This compound is a nitrosamine-containing derivative designed as a reference standard for impurity testing in pharmaceutical quality control. It is structurally related to dasatinib and is used for analytical method development and regulatory compliance studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2135905-86-9
Dasatinib
pharmaceutical raw material
Dasatinib monohydrate
pharmaceutical raw material
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate
research compound
7-(2,2-Diphenylethenyl)-1,2,3,3a,4,8b-hexahydro-4-(4-methylphenyl)cyclopent[b]indole
research compound
Hexyllithium
research compound
Methyl 5-bromo-3-methylpyridine-2-carboxylate
research compound
N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(4-nitrosopiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
YJKQGCKTMDSUPI-UHFFFAOYSA-N
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)N=O